Joeri K. Tijdink
Joeri K. Tijdink is an assistant professor of Ethics, Law & Medical humanities at Amsterdam University Medical Centers (UMC)
Articles by Joeri K. Tijdink
Page 1 of 1 - 1 Total Items
January 2025, Issue 1
Why Do Some People Get Drunk Faster Than Others?
Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.
View this IssueResearch Resources
Sex Differences in Neurological Research
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
New Frontiers in Vaccine Development
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
New Approaches for Decoding Cancer at the Single-Cell Level
In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.
Organoids as a Tool for Tissue Regeneration Research
Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.
Products
Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces key accreditations in recognition of excellence in data security, AI innovation, and commitment to continuous improvement.
Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators
Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance
Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.
Accelerating Mycoplasma Testing for Targeted Therapy Development
Tailored nucleic acid extraction and amplification methods help scientists overcome the challenges of detecting Mycoplasma contamination in advanced therapy medicinal products.
